GNH USA

Europe — EMA

Isdn 40 Retard

GNH USA supplies Isdn 40 Retard (Isosorbide Dinitrate), a nitrate vasodilator for angina pectoris and heart failure. Request a quote for global supply.

Isosorbide Dinitrate

Request sourcing

1
Pack/s

What is Isosorbide Dinitrate?

Isosorbide dinitrate, the active ingredient in Isdn 40 Retard, is a nitrate vasodilator presented as a tablet for oral use. It is employed to relieve angina pectoris and to manage certain forms of heart failure in adult patients.

GNH USA supplies Isdn 40 Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for cross‑border distribution.

What is Isosorbide Dinitrate used for?

Isosorbide dinitrate is an oral nitrate vasodilator used in the management of cardiovascular conditions.

- Angina pectoris: reduces frequency and severity of chest pain episodes by decreasing myocardial oxygen demand. - Chronic stable angina prophylaxis: provides preventive relief of exertional angina in patients with known coronary artery disease. - Heart failure: improves symptoms by lowering preload and afterload, thereby enhancing cardiac output.

What are the side effects of Isosorbide Dinitrate?

Isosorbide dinitrate may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: throbbing pain often occurring after the first dose. - Flushing: warm sensation and reddening of the skin. - Dizziness: light‑headed feeling, especially when standing quickly. - Hypotension: low blood pressure causing faintness. - Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure leading to syncope. - Reflex tachycardia: rapid heart rate as a compensatory response. - Methemoglobinemia: elevated methemoglobin causing cyanosis. - Allergic reactions: rash, itching, swelling, or anaphylaxis.

What precautions apply to Isosorbide Dinitrate?

When prescribing isosorbide dinitrate, clinicians should consider several safety measures to minimize risk.

- Assess cardiovascular status: evaluate blood pressure and heart rate before initiation. - Avoid abrupt discontinuation: taper the dose to prevent rebound angina. - Concomitant phosphodiesterase‑5 inhibitors: contraindicated due to risk of profound hypotension. - Hepatic or renal impairment: use with caution and monitor for accumulation. - Pregnancy and lactation: safety not established; use only if potential benefit justifies potential risk. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

What does Isosorbide Dinitrate interact with?

Isosorbide dinitrate can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Sildenafil, tadalafil, vardenafil: combined use may cause severe hypotension. - Other nitrates (e.g., nitroglycerin): additive vasodilatory effect leading to dangerous blood pressure fall.

Moderate Interactions (Monitor Closely): - Antihypertensives (beta‑blockers, ACE inhibitors): may enhance blood pressure‑lowering effect. - Diuretics: increase risk of volume depletion and hypotension. - Alcohol: can potentiate vasodilatory response and dizziness.

Frequently asked questions

What is Isdn 40 Retard used for?+
Isdn 40 Retard contains isosorbide dinitrate, a nitrate vasodilator prescribed to relieve episodes of angina pectoris and to improve symptoms in patients with certain types of heart failure by lowering cardiac workload.
How does isosorbide dinitrate work?+
The drug is converted in the body to nitric oxide, which activates guanylate cyclase in vascular smooth muscle. This raises cyclic GMP levels, causing relaxation of veins and arteries, reducing preload and afterload, and consequently decreasing myocardial oxygen demand.
What is the usual dose of Isdn 40 Retard?+
The appropriate dose is determined by the prescribing clinician based on the individual’s condition, response, and tolerance. Dosage adjustments are made according to therapeutic effect and any adverse reactions observed.
Is Isdn 40 Retard safe during pregnancy or breastfeeding?+
Safety data for isosorbide dinitrate in pregnancy and lactation are limited. It should only be used when the potential benefit outweighs any possible risk to the fetus or infant, and under close medical supervision.
How do I order Isdn 40 Retard from GNH USA?+
Enquiries are submitted via the product page on gnh-usa.com, where you specify the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Isdn 40 Retard compare with other anti‑anginal drugs?+
Isosorbide dinitrate offers a longer‑acting oral option compared with short‑acting nitrates such as nitroglycerin. Its extended‑release formulation provides more stable plasma levels, reducing the frequency of dosing and minimizing peaks that can cause severe headaches.
How should Isdn 40 Retard be stored and handled?+
Store the tablets at ambient temperature, preferably below 25 °C, in the original container. Protect them from moisture, direct sunlight and excessive heat to maintain potency throughout the shelf life.
How is Isdn 40 Retard administered?+
Isdn 40 Retard is taken orally, usually with a glass of water. The extended‑release tablets are swallowed whole and should not be crushed, chewed, or split, as this could alter the release profile.
What are the most serious risks to watch for with Isdn 40 Retard?+
Serious adverse events include severe hypotension, reflex tachycardia, methemoglobinemia, and allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience fainting, rapid heartbeat, cyanosis, or signs of a severe allergic response.
Who should not use Isdn 40 Retard?+
The medication is contraindicated in patients taking phosphodiesterase‑5 inhibitors, those with known hypersensitivity to isosorbide dinitrate or other nitrates, and individuals with severe hypotension or certain types of cardiogenic shock.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Isosorbide Dinitrate
Route
Oral Use
Manufacturer
Aliud Pharma Gmbh
Origin
EU

Related products